
Blends
BPC-157 and TB-500 in one vial, 10 mg each.
The two repair-research peptides most often studied side by side, pre-blended so a protocol runs from a single vial.
Both peptides in this vial were recommended for the FDA's 503A compounding list by an advisory panel in July 2026. The blend itself is not on that list, and no rule has been issued.
For laboratory research use only. Not for human consumption. Statements have not been evaluated by the FDA.
Verified reviews
No reviews yet — be the first.